Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein overexpressed on prostate cancer (PC) cells and serves for tumor-targeted imaging with positron emission tomography/computed tomography (PET/CT) [1]. The gene discussed is FOLH1; the disease is neoplasm.